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BRIEF COMMUNICATION
SINGLE STEP POLYMERASE CHAIN REACTION (PCR) FOR THE
DIAGNOSIS OF THE Leishmania (Viannia) SUBGENUS
Byanca Regina PAIVA(1,2), Luciana Neves PASSOS(3), Aloisio FALQUETO(3), Rosely dos S. MALAFRONTE(1) & Heitor Franco de ANDRADE Jr.(1,2)
SUMMARY
In Brazil, the main etiologic agent of Leishmaniasis that frequently presents with mucosal involvement belongs to the Viannia
subgenus. The therapeutic conduct in this disease depends on the parasitological diagnosis, and classical methods are restricted in
identifying the agent. In this paper we describe a polymerase chain reaction (PCR), which uses primers designed from mini-exons
repetitive sequences. The PCR amplifies a 177bp fragment that can distinguish (Viannia) from (Leishmania) subgenus. This test
could be a useful diagnostic tool.
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INTRODUCTION
Leishmaniasis is the most diverse and complex of all vector borne
diseases in terms of both its ecology and epidemiology. Despite the fact
that only 30 countries have notified the disease, it is endemic in 88
countries, where a total of 12 million people are infected (WHO, 1998).
Ninety percent of all cases of cutaneous leishmaniasis (CL) occur in
Iran, Saudi Arabia, Syria, Afghanistan (Old World), Peru and Brazil
(South America). In the last 20 years, CL has been increasing in Latin
America, particularly in Brazil (DEANE & GRIMALDI Jr., 1985).
In Brazil, six species of Leishmania belonging to (Leishmania)
and (Viannia) subgenera are responsible for CL clinical forms in human
beings. Viannia subgenus comprises the following species: Leishmania
(V.) braziliensis, Leishmania (V.) guyanensis, Leishmania (V.) naiffi,
Leishmania (V.) shawi and Leishmania (V.) lainsoni. All these species
are present in Brazil, most of them in the Amazon region (GONTIJO
& CARVALHO, 2003).
Determining the infecting species is an important step in analyzing
epidemiological conditions of transmission and in determining
prognosis and adequate chemotherapy. Classical methods, such as
microscopic analysis and isolation of the parasites in culture, are
laborious and inaccurate as many species are often morphologically
indistinguishable (MAGILL, 2000).
Molecular approaches have recently allowed diagnosis based on
PCRs. These are usually performed with repeated gene sequences such
as mini-exon, kDNA or ribosomal genes (ARANSAY et al., 2000;
MICHALSKY et al., 2002; MIRANDA et al., 2002). The nuclear mini-
exon genes consist of 200 copies in tandem separated in transcribed
and non-transcribed genes. The transcribed region consists of a highly
conserved exon with 39 nucleotides and a moderately conserved intron
among species of the same genera or subgenera. The non-transcribed
region consists of a variable intergenic region among Leishmania
species that is absent in vertebrate hosts and vectors (FERNANDES et
al., 1994). We designed a new set of primers based on nuclear mini-
exon genes and sought amplification based on subgenus Viannia in
order to distinguish these subgenera from others and to improve the
diagnosis of Leishmaniasis.
MATERIAL AND METHODS
Parasites and positive tissue samples: Strains of (Viannia)
subgenus: Leishmania (Viannia) braziliensis MHOM/BR/1975/M2903
and Leishmania (Viannia) guyanensis MHOM/BR/1975/M4147. Strains
of Leishmania subgenus: Leishmania (Leishmania) amazonensis IFLA/
BR/67/PH8 and Leishmania (Leishmania) chagasi MHOM/BR/1974/
PP75(M2682). All were kept in liquid nitrogen or cultivated in
supplemented M199 medium, and positive Leishmania human tissue
(LW) obtained from the laboratory of Prof. Lucile Floeter Winter, ICB,
University of São Paulo, were used.
Reliability of the clinical samples: In order to confirm the
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sensitivity and specificity of mini-exon primers, a blind test was carried
out with 92 samples from Espírito Santo. Seventy-one samples were
confirmed as cutaneous Leishmaniasis in clinical, parasitological and
epidemiological diagnoses and were stored in formol (LF) or embedded
in paraffin (LP). 34 samples were stored in formol and 58 were
embedded in paraffin. Of those stored in formol, 21 were related to
other dermatological diseases.
DNA extraction: SAMBROOK et al. (1989) phenol/chloroform
method or QUIamp (QIAGEN Co.) Kit were used for DNA extraction.
Primer design and PCR assay: Repetitive mini-exon sequences
described by DEGRAVE, W. (accession number X69442) were used
to design the specific primers for L. (V.) braziliensis. Consensus
sequences for each primer were constructed manually and confirmed
by DNASTAR-Laser Gene program.
The following primers which amplify a 177bp product were used:
Forward (LV1) 5’ CGTCTTCCGGCAACATTT 3’ and Reverse (LV2)
5’ CGTTAGTTGGAAGCCCAAGG 3’. A 25 µl reaction mixture
containing DNA, 1 µM of each primer of 0.2 mM of dNTPs, 2.5%
formamide, 1x Taq buffer (Biotools B&M Labs., S.A.) and 0.5 units
of Taq DNA polymerase was placed in a thermal cycler (Eppendorf
Mastercycler gradient serial No. 5331) at 95 oC for five minutes for
initial denaturation, followed by 35 cycles at 95 oC for one minute,
55 oC for 30 seconds, 73 oC for one minute and then 72 oC for six
minutes for final extension. Products (5 µl each) were electrophoresed
on 6% polyacrilamide gel and 1.5% of agarose gel.
Cloning and sequencing - PCR products: PCR products were
ligated into pGEM T-Easy vector (Promega), transformed into CaCl2
competent E. coli DH5-α bacteria and plated on LB-ampicillin plates.
White colonies were grown overnight on 3 ml LB-amp and plasmids
were prepared for sequencing following the procedure for the GFX
Micro Plasmid Prep Kit (Amersham/Pharmacia). A minimum of two
clones were labeled by Cy5 Autoread Sequencing Kit and sequenced
by ALFexpress DNA Sequencer (Pharmacia). Sequences were
submitted to Genebank and the results were analyzed.
Sensitivity and specificity assays: The estimated DNA
concentration was obtained by comparison of the band from genomic
purified Leishmania DNA loaded in a 2% agarose gel with the Low
DNA Mass Ladder (Invitrogen), in accordance with the manufacturer’s
instructions. In order to determine the PCR sensitivity, the reaction
was carried out with several DNA concentrations diluted from 18pg to
0.15pg.
The specificity test was analyzed using purified human DNA (from
peripheral blood mononuclear cells) and genomic DNAs from Lu.
longipalpis and Plasmodium falciparum. DNAs from Kinetoplastida
genera, T.cruzi (blood forms) and Crithidia spp (cultured organisms)
were also tested.
RESULTS AND DISCUSSION
The correct identification of Leishmania species is crucial, as this
will affect the type of clinical survey required. Control of Leishmaniasis
requires knowledge of the ecology and the epidemiology of the disease.
The mini-exon genes in Kinetoplastid protozoa are present in 100-
200 tandemly repeated copies in the nuclear genome (FERNANDES
et al., 1994). This characteristic has been shown to be a useful tool for
identifying the subgenus or Leishmania species. Based on these
sequences, which were deposited in Genebank (number X69442), a
pair of primers (LV1 and LV2) to identify the (Viannia) complex was
designed.
In order to standardize the annealing temperature, a gradient of 12
temperatures varying from 45 oC to 65 oC was used. Clear fragments
were visualized with annealing temperatures of 55 oC and 58 oC. We
chose 55 oC as the annealing temperature in our PCR reaction.
The species specific primer was tested, using DNA extracted from
the M2903 and M4147 strains of L. (V.) braziliensis and L. (V.)
guyanensis respectively and human positive Viannia samples embedded
in paraffin and formol (LW, LP and LF) as a positive control. As shown
in Figures 1, 2, and 3 a 177bp fragment was amplified. These fragments
were cloned, sequenced and (Viannia) subgenus was confirmed by
Genebank analysis. The specificity assay was carried out and LV1 and
LV2 primers did not amplify DNA from L. (L.) amazonesis and L. (L.)
chagasi or other microorganisms such as P. falciparum, T. cruzi,
Crithidia sp, human DNA and Phlebotomus sp. DNA (Lu. longipalpis)
Fig. 2 - PCR amplification products. MW 50bp ladder DNA size marker (Promega); 1- LPa;
2- LPb; 3- LPc; 4- LPd; 5- LPe; 6- L. braziliensis (M2903 strain); 7- L. amazonensis (IFLA/
BR/67/PH8 strain); 8- L. chagasi (M2682 strain)
Fig. 1 - PCR amplification products. MW 50bp DNA ladder size marker (Invitrogen); 1-
LFa; 2- LFb; 3- LFc; 4- L. braziliensis (M 2903 strain); 5- LW; 6- negative control.
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(Fig. 3). In the blind test using LV1 and LV2 primers, 62.1% (36/58)
and 46.1% (6/13) of LP and LF respectively were PCR positive. Of the
negative samples, all PCRs but one were negative.
PCR reaction detected as little as 0.15pg of Leishmania DNA, but
this detection varied according to the DNA sample. Our reaction was
able to detect 1.5 parasites, as MYLER & STUART (2000) reported
that one Leishmania contains 100fg of DNA.
Several authors reported molecular approaches for identifying the
subgenus and species of Leishmania (CASTILHO et al., 2003;
RODRIGUES et al., 2002; UEZAT et al., 2001; FERNANDES et al.,
1999) but some of these methods are either laborious or the DNA
sequences used as target are usually present as single or low copy.
Based on these reports, a comparison was undertaken between LV1
and LV2 mini-exon PCR and PCR-RFLP (VOLPINI et al., 2004).
Leishmaniasis LP samples were tested for PCR-RFLP and 44% (25/
58) were found to be positive for (Viannia) subgenus (PAIVA et al.,
2003). These results are similar to those from LV1 and LV2 mini-exon
primers. PCR-RFLP, however, needs a two-step PCR reaction to identify
the Leishmania subgenus whereas the LV1 and LV2 mini-exon primers
can identify (Viannia) subgenus parasites in only one step.
Based on these results, we believe that LV1 and LV2 primers could
be useful in identifying (Viannia) complex. Studies using laboratory-
infected sandflies are being carried out. Once the laboratory reaction
has been standardized our next goal is to use these primers to detect
infected sandflies in the field.
RESUMO
Reação de polimerização em cadeia (PCR) em etapa única para
diagnóstico de Leishmania do subgênero (Viannia)
No Brasil, o principal agente etiológico da leishmaniose,
apresentando freqüentemente comprometimento das mucosas, pertence
ao subgênero (Viannia). A conduta terapêutica no tratamento da
leishmaniose depende de seu diagnóstico parasitológico e os métodos
clássicos restringem sua identificação. Neste trabalho, descrevemos
uma reação de PCR, utilizando primers desenhados a partir de
seqüências repetitivas de mini-exons, que amplificam um fragmento
de 177pb e que são capazes de distinguir o subgênero (Viannia) do
subgênero (Leishmania), tornando-se uma ferramenta útil no
diagnóstico desta doença.
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